×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Liver neoplasms
0.690
Biomarker
BEFREE
In this study, we demonstrated that necrosis-inducing peptide P16 kills human glioblastoma cancer cells and primary human hepatoma or renal cancer cells isolated from patients who had not responded to standard treatments.
31206614
2019
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Liver neoplasms
0.690
Biomarker
CTD_human
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
27064257
2016
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Liver neoplasms
0.690
Biomarker
BEFREE
In summary, a senescence-inducing program was found in hepatocytes with increased β-catenin levels and a positive selection of hepatocytes lacking p16(INK4a ), by epigenetic silencing, drives the development of liver tumors in mice with reduced APC expression (Apc(580S) mice).
25270420
2015
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Liver neoplasms
0.690
PosttranslationalModification
BEFREE
Herein, we evaluated CDKN2A promoter methylation and p16 protein expression for the differentiation of hepatocellular carcinoma (HCC) from other liver tumors .
20569442
2010
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Liver neoplasms
0.690
AlteredExpression
BEFREE
Intriguingly, we found no evidence that Bmi1 regulates Ink4A /Arf expression in both in vitro and in vivo systems of liver tumor development.
19934271
2009
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Liver neoplasms
0.690
AlteredExpression
BEFREE
Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells.
18949401
2008
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Liver neoplasms
0.690
Biomarker
RGD
Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer.
16317707
2005
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Liver neoplasms
0.690
Biomarker
CTD_human
Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer.
16317707
2005
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Liver neoplasms
0.690
AlteredExpression
BEFREE
Frequent p16ink4a inactivation is an early and frequent event of intraductal papillary neoplasm of the liver arising in hepatolithiasis.
15619210
2004
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Liver neoplasms
0.690
Biomarker
BEFREE
Additionally, we analysed the methylation status of p16(INK4a ) and other cancer-related genes in the same liver tumors .
12660822
2003
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Liver neoplasms
0.690
Biomarker
CTD_human
Abnormalities of the ARF-p53 pathway in primary angiosarcomas of the liver.
12378512
2002
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Liver neoplasms
0.690
Biomarker
RGD
De novo methylation of the p16INK4A gene in early preneoplastic liver and tumors induced by folate/methyl deficiency in rats.
12359353
2002
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Liver neoplasms
0.690
Biomarker
RGD
Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis, and methylation of p16(INK4A) exon 1 in hepatocellular carcinoma.
11301474
2001
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Liver neoplasms
0.690
GeneticVariation
BEFREE
p16INK4a and beta-catenin alterations in rat liver tumors induced by NNK.
11238187
2001
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Liver neoplasms
0.690
Biomarker
BEFREE
There were no deletions of p16 and p15 in any of the hepatoma cell lines.
9058294
1997
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Liver neoplasms
0.690
Biomarker
HPO